An international team of researchers led by Dr. Eleanor Fish, Scientist Emeritus at the Toronto General Hospital Research Institute, UHN, and professor in the University of Toronto‘s Department of Immunology, has shown for the first time that an antiviral drug can help speed up the recovery of COVID-19 patients.
According to the new study, published Friday in Frontiers in Immunology, treatment with interferon(IFN)- a2b may significantly accelerate virus clearance and reduce levels of inflammatory proteins in COVID-19 patients.
The research team found that treatment with this drug, which has been used clinically for many years, significantly reduced the duration of detectable virus in the upper respiratory tract, on average by about seven days. It also reduced blood levels of interleukin(IL)-6 and C-reactive protein (CRP), two inflammatory proteins found in COVID-19 patients.
Dr. Fish says the research team considered IFN-a therapy for COVID-19 after they demonstrated interferon provided therapeutic benefit during the SARS outbreak of 2002 and 2003.
“Rather than developing a virus-specific antiviral for each new virus outbreak, I would argue that we should consider interferons as the ‘first responders’ in terms of treatment,” says Dr. Fish.
“Interferons have been approved for clinical use for many years, so the strategy would be to ‘repurpose’ them for severe acute virus infections.”
Boosting a natural defence mechanism
Interferons are a group of signaling proteins released by the human body in response to all viruses. As Dr. Fish explains, they are a “first line of defence.”
They target different stages of a virus’s life cycle, inhibiting them from multiplying. They also boost an immune response by activating different immune cells to clear an infection. Some viruses, however, can block this natural defense mechanism.
“But it is possible to override this block. If a virus blocks interferon production, then treating with interferon can offset this.”
Study details
The researchers conducted this exploratory study on a group of 77 patients with COVID-19 in Wuhan, China. These patients were admitted to Union Hospital, Tongii Medical College, between January 16 and February 20, 2020. They represented moderate cases of the disease as none of the patients required intensive care or prolonged oxygen supplementation or intubation.
Despite the study’s limitations of a small, non-randomized group of patients, the work provides several important and novel insights into COVID-19 disease, notably that treatment with IFN-a2b can accelerate viral clearance from the upper respiratory tract and also reduce circulating levels of inflammatory factors that are associated with severe COVID-19.
Dr. Fish says a randomized clinical trial is a crucial next step. According to her, a clinical trial with a larger group of infected patients who are randomized to treatment or placebo would further this research.
In the meantime, the findings from this study are the first to suggest therapeutic efficacy of IFN-a2b as an available antiviral intervention for COVID-19, which may also benefit public health measures by shortening the duration of viral clearance and therefore slowing the tide of the pandemic.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Recovery of COVID-19 patients
- Buy into this blue-chip recovery story
Management missteps and legal woes are vanishing in the rear-view mirror at this pharma giant ...
- Vijayawada: Familiarity breeds compassion towards patients
Neighbours are turning into good Samaritans for those who are down with Covid-19. Discrimination towards Covid-19 patients has come down significantl ...
- Marcos touts release of COVID-19 frontliners’ emergency allowance
President Marcos highlighted the distribution of the bulk of the pandemic emergency allowance to frontliners in his message for Health Workers’ Day, assuring members of the sector that the government ...
- Hospital’s artist in residence key player in girl’s recovery
They planned to use a mix of her cord blood and stem cell harvest for transplant in May 2020, but that plan was thwarted by the COVID-19 pandemic ... Virginia loved it. “I serve patients and families ...
- Impact of the COVID-19 Pandemic on Regular Emergency Department Users
Patients with regular high-severity ED use might benefit ... as part of a larger project (RECOVER: Understanding COVID-19 Impacts on Health Outcomes and Equity in the New England Region). Author ...
Go deeper with Google Headlines on:
Recovery of COVID-19 patients
[google_news title=”” keyword=”recovery of COVID-19 patients” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Antiviral drug
- Chris Cuomo brutally mocked for taking U-turn on anti-viral drug Ivermectin: ‘He’s such a hypocrite’
NewsNation anchor Chris Cuomo recently claimed that he is facing side-effects caused by a COVID-19 vaccine. And now in his latest appearance on Patrick Bet-David's podcast, Cuomo revealed that he ...
- Chris Cuomo Makes Ivermectin About-Face After Denouncing Its Use for COVID: 'I Am Now Taking a Regular Dose'
Chris Cuomo's stance on Ivermectin as a theraputic drug for COVID-19 has done a complete 180, as the news anchor who once said on CNN that anyone promoting it should be "shamed" now says he's "taking ...
- NanoViricides, Inc.: A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE Ameri ...
- A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
In addition, we believe that the combination of NV-387 and tecovirimat could reduce the potential for escape resistant generation against tecovirimat, as is known with other drug combination studies ...
- Hong Kong ‘death by misadventure’ verdict after kidney disease patient died of liver failure when doctors failed to give her needed drug
Coroner praises Michelle Wu, the daughter of the late Tang Kwai-sze, who was 44, for her offer to donate part of her own liver to her mother, and for her role in the inquest.
Go deeper with Google Headlines on:
Antiviral drug
[google_news title=”” keyword=”antiviral drug” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]